ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
ZimVie (Nasdaq: ZIMV) has entered into an exclusive distribution agreement with Osstem Implant to expand its dental implant presence in China. The strategic partnership leverages Osstem's market-leading position and extensive distribution network spanning over 90 Chinese cities.
Osstem Implant, established in China since 2006, conducts nearly 500 clinical training sessions annually and will have exclusive commercial rights to distribute ZimVie implant systems in the Chinese market, which has an estimated demand of over 10 million units annually.
ZimVie (Nasdaq: ZIMV) ha stipulato un accordo di distribuzione esclusiva con Osstem Implant per ampliare la sua presenza nel settore degli impianti dentali in Cina. Questa collaborazione strategica sfrutta la posizione di leadership di Osstem sul mercato e la sua vasta rete di distribuzione che copre oltre 90 città cinesi.
Osstem Implant, presente in Cina dal 2006, organizza quasi 500 sessioni di formazione clinica ogni anno e deterrà i diritti commerciali esclusivi per la distribuzione dei sistemi di impianti ZimVie nel mercato cinese, che ha una domanda stimata di oltre 10 milioni di unità all'anno.
ZimVie (Nasdaq: ZIMV) ha firmado un acuerdo exclusivo de distribución con Osstem Implant para expandir su presencia en implantes dentales en China. Esta asociación estratégica aprovecha la posición líder de Osstem en el mercado y su extensa red de distribución que abarca más de 90 ciudades chinas.
Osstem Implant, establecida en China desde 2006, realiza casi 500 sesiones de formación clínica anuales y tendrá los derechos comerciales exclusivos para distribuir los sistemas de implantes de ZimVie en el mercado chino, que tiene una demanda estimada de más de 10 millones de unidades al año.
ZimVie (나스닥: ZIMV)는 중국 내 치과 임플란트 사업 확대를 위해 Osstem Implant와 독점 유통 계약을 체결했습니다. 이번 전략적 파트너십은 Osstem의 시장 선도 위치와 중국 내 90개 이상의 도시에 걸친 광범위한 유통망을 활용합니다.
2006년부터 중국에서 활동해 온 Osstem Implant는 연간 약 500회의 임상 교육 세션을 진행하며, 중국 시장에서 ZimVie 임플란트 시스템의 독점 상업적 유통 권한을 갖게 됩니다. 중국 시장의 연간 수요는 1,000만 개 이상으로 추산됩니다.
ZimVie (Nasdaq : ZIMV) a conclu un accord de distribution exclusif avec Osstem Implant afin d’étendre sa présence dans le domaine des implants dentaires en Chine. Ce partenariat stratégique s’appuie sur la position de leader d’Osstem sur le marché et son vaste réseau de distribution couvrant plus de 90 villes chinoises.
Osstem Implant, implantée en Chine depuis 2006, organise près de 500 sessions de formation clinique par an et disposera des droits commerciaux exclusifs pour distribuer les systèmes d’implants ZimVie sur le marché chinois, dont la demande est estimée à plus de 10 millions d’unités par an.
ZimVie (Nasdaq: ZIMV) hat eine exklusive Vertriebsvereinbarung mit Osstem Implant geschlossen, um seine Präsenz im Bereich Zahnimplantate in China auszubauen. Die strategische Partnerschaft nutzt Osstems marktführende Position und ein umfangreiches Vertriebsnetz, das über 90 chinesische Städte umfasst.
Osstem Implant, seit 2006 in China tätig, führt jährlich fast 500 klinische Schulungen durch und erhält die exklusiven kommerziellen Vertriebsrechte für ZimVie-Implantatsysteme auf dem chinesischen Markt, der eine geschätzte Nachfrage von über 10 Millionen Einheiten jährlich aufweist.
- Access to China's large dental implant market of over 10 million units annually
- Partnership with market leader Osstem provides immediate access to 90+ Chinese cities
- Leverages Osstem's established network and 500 annual clinical training sessions
- Strategic expansion aligns with ZimVie's global growth objectives
- Exclusive distribution agreement may limit direct market control
- Dependence on Osstem's performance for success in Chinese market
Insights
ZimVie's partnership with market leader Osstem gives immediate access to China's massive dental implant market without infrastructure investment.
This exclusive distribution agreement represents a significant strategic move for ZimVie to penetrate the Chinese dental implant market, which the release identifies as exceeding
The partnership structure is particularly advantageous for ZimVie. By leveraging Osstem's existing infrastructure—built since their 2006 market entry—and their clinical education program (conducting nearly 500 training sessions annually), ZimVie gains immediate market access without the capital expenditure and regulatory navigation challenges typically associated with direct market entry.
For ZimVie, this agreement offers a capital-efficient globalization approach. The company can position its premium implant systems within an established distribution network while benefiting from Osstem's market knowledge and customer relationships. The exclusive commercial rights granted to Osstem creates a protected channel for ZimVie's products, though it also means their success in China becomes dependent on Osstem's execution.
This partnership follows a pattern seen across the medical device industry, where Western manufacturers often partner with regional leaders to access Asian markets. Such arrangements typically allow for faster market penetration and reduced regulatory friction compared to direct entry strategies. For a dental implant manufacturer like ZimVie, establishing presence in China—with its massive patient population and growing middle class seeking advanced dental care—represents significant long-term growth potential.
Strategic Partnership Provides Market Presence in Growing Chinese Market
PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s global presence to further penetrate the large, growing Chinese implant market—estimated at greater than 10 million units annually1—and enhance customer access to its innovative implant portfolio.
Osstem Implant is the market-leading provider of dental implants in China, with broad, established distribution channels. Since entering the Chinese market in 2006, Osstem has built a robust presence in over 90 cities and conducts nearly 500 clinical training sessions annually. This commitment to education, combined with high-quality products and extensive clinical validation, has earned Osstem strong trust among dental professionals and enabled the company to build a reliable and expansive distribution network. Under the agreement, Osstem Implant will have the exclusive commercial responsibility for ZimVie implant systems within the growing Chinese market, providing greater product selection for its vast customer base.
"Partnering with Osstem, a respected leader known for exceptional service and a strong portfolio of high-quality products, presents a superior opportunity for ZimVie to expand and grow in the Chinese market," said Vafa Jamali, Chairman of the Board and Chief Executive Officer of ZimVie.
“We are excited to partner with ZimVie, a company with outstanding clinical expertise and technological excellence,” said Michael Kim, Head of Osstem Implant’s China operations. “This collaboration allows us to offer more choices to our dental customers and patients. Through our strong clinical education system and extensive sales network, we will continue working to ensure that more dentists and patients benefit from high-quality implant treatments.”
The agreement reflects the strength and differentiation of ZimVie's premium implants, which are designed for precision, esthetics, and durability. It underscores the company’s commitment to innovation, global expansion, and its vision of creating great customer experiences to become the preferred dental implant brand for clinicians and patients worldwide.
1. National Conference on Oral Implantology; Qianzhan Industrial Research Institute
About ZimVie
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at www.ZimVie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.
About Osstem Implant
Founded in South Korea in 1997 by a dentist, Osstem Implant has grown into the world’s largest dental implant manufacturer and the top dental company in the Asia-Pacific region. With 37 overseas subsidiaries in 33 countries and distribution in over 90 countries, Osstem delivers high-quality products and integrated dental solutions. The company is committed to contributing to better human health by enabling dentists to provide better treatment through bold investments in R&D, extensive clinical validation, and ongoing education programs.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.
Media Contact Information:
ZimVie
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130
Investor Contact Information:
Gilmartin Group LLC
Webb Campbell • Webb@gilmartinir.com
FAQ
What is the new partnership between ZimVie (ZIMV) and Osstem Implant?
How large is the Chinese dental implant market that ZimVie (ZIMV) is entering?
What is Osstem Implant's presence in China?
How will the distribution agreement benefit ZimVie (ZIMV)?
Who will be responsible for ZimVie's implant systems distribution in China?
